Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04236154 · ClinicalTrials.gov registry record · Phase 1
"Prescribing" Exercise to Cancer Patients At High-Risk for Falls
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 34
- Enrollment target
NCT04236154: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT04236154 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04236154, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 34 participants
- Enrollment target
Study Summary
Falls are common and catastrophic in cancer patients. Cancer patients are vulnerable to falls due to muscle loss. In prescribing exercise in a data driven manner to cancer patients, our hypothesis is this "prescription" for exercise will eventually be demonstrated to reduce the occurrence of injurious falls.
Interventions
- OTHER Pedometer
- OTHER Actigraph
- OTHER Perturbation Treadmill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2020-09-03 |
| Est. Completion | 2024-08-26 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04236154
The ClinicalTrials.gov registry entry for NCT04236154 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Pedometer is the first listed.
NCT04236154 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04236154 about?
NCT04236154 is a clinical study titled ""Prescribing" Exercise to Cancer Patients At High-Risk for Falls". Falls are common and catastrophic in cancer patients. Cancer patients are vulnerable to falls due to muscle loss. In prescribing exercise in a data driven manner to cancer patients, our hypothesis is this "prescription" for exercise will eventually be demonstrated to reduce the occurrence of injurio...
What is the current status of trial NCT04236154?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 34 participants. The study started on 2020-09-03. Estimated completion is 2024-08-26.
What interventions are being tested in trial NCT04236154?
The interventions under investigation include: Pedometer (OTHER), Actigraph (OTHER), Perturbation Treadmill (OTHER).
Who is sponsoring clinical trial NCT04236154?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.